Tags: Case, Legal Case, Supreme Court Of The United States Case, Unit Of Work.
Association for Molecular Pathology v. Myriad Genetics 569 U.S. 12-398 (2013) was a case challenging the validity of gene patents in the United States specifically challenging certain claims in issued patents owned or controlled by Myriad Genetics that cover isolated DNA sequences methods to diagnose propensity to cancer by looking for mutated DNA sequences and methods to identify drugs using isolated DNA sequences. Prior to the case the U.S.